Navigation Links
Life Technologies Announces Launch of 2010 Online Annual Review
Date:3/31/2011

CARLSBAD, Calif., March 31, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the availability of its 2010 Online Annual Review on its corporate website, available here: http://bit.ly/h5tAgn

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

Highlights in the 2010 Online Annual Review include video profiles about Life Technologies, its customers, its culture and its future, giving a first hand look at the company's world-class operations.  The Online Annual Review also features interviews with senior management about how Life Technologies is providing researchers with the tools and technologies that will ultimately help to solve some of the greatest challenges of the 21st century.

The 2010 Online Annual Review, a follow-up to Life Technologies' award-winning video annual reports, is a more sustainable alternative to a printed annual report, and gives investors, customers and employees a unique, innovative glimpse into the company and its accomplishments in 2010.

The Online Annual Review also features links to previously released financial, 10-K and Proxy voting information from the company's 2010 Annual Report.

To access the 2010 Online Annual Review, please visit:

http://media.invitrogen.com.edgesuite.net/2010-Annual-Review/default.html

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, Gibco, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com. Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

Life Technologies' Safe Harbor Statement

This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

Life Technologies Contact:
Tim Ingersoll
Corporate Communications
760-918-3883
Tim.ingersoll@lifetech.com


'/>"/>
SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information
2. BioStorage Technologies Appoints New Director of Business Development for European Operations
3. Reportlinker Adds Quantum Dots: Technologies and Global Markets
4. Intrasphere Technologies Launches SafetyXpress(TM) for Oracle(R) Argus Safety
5. Veran Medical Technologies Completes Financing Worth More Than $15 Million
6. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results
7. Netsmart Technologies CMHC/MIS Behavioral Health Software Passes ARRA Certification Tests
8. Honeywells Envergent Technologies Selected by Malaysian Company for Renewable Energy Project
9. Palatin Technologies, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
10. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on March 11, 2011
11. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):